Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats
- PMID: 12661918
- DOI: 10.1291/hypres.26.97
Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats
Abstract
Since Y-27632, a specific inhibitor of Rho kinase, decreases the blood pressure in spontaneously hypertensive rats (SHR), it is suggested that Rho kinase is involved in the pathophysiology of hypertension. However, the effects of Y-27632 on isolated resistance arteries have never been determined. This study aimed to examine the possible role of the Rho/Rho kinase pathway during arterial contraction in isolated resistance arteries from SHR. The profile of arterial relaxant effects of Y-27632 was compared in endothelium-denuded strips of small and large mesenteric arteries from 13-week-old SHR and normotensive Wistar-Kyoto rats (WKY). The addition of 10(-6) mol/l norepinephrine (NE) to the strips of small arteries caused an initial peak followed by a tonic contraction in both strains. There was no difference between the two strains in either the initial peak or the tonic contraction. The addition of Y-27632 (0.3-3 micromol/l) to the tonic contraction of these strips caused a concentration-dependent relaxation in both strains. The relaxation was greater in SHR than in WKY. Similar results were observed in strips of large arteries. The relaxant effects of Y-27632 were greater in the large artery than in the small artery. Y-27632 also induced a concentration-dependent relaxation in strips precontracted with 65.9 mmol/l K+ depolarization. In both arteries, this relaxation was greater in SHR. The relaxant effects of Y-27632 were greater in the K+-contracted strips than in the NE-contracted strips. We conclude that Y-27632 shows the greater relaxant effects on the SHR arteries, and the effects are more evident in the large artery and in the K+-contracted strips.
Similar articles
-
Increased activity of calcium channels and Rho-associated kinase in the basilar artery during chronic hypertension in vivo.J Hypertens. 2002 May;20(5):879-84. doi: 10.1097/00004872-200205000-00022. J Hypertens. 2002. PMID: 12011648
-
Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.J Physiol. 2003 Sep 15;551(Pt 3):855-67. doi: 10.1113/jphysiol.2003.047050. Epub 2003 Jul 9. J Physiol. 2003. PMID: 12853654 Free PMC article.
-
Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats.Eur J Pharmacol. 1994 Sep 22;263(1-2):121-31. doi: 10.1016/0014-2999(94)90532-0. Eur J Pharmacol. 1994. PMID: 7529710
-
Augmented contributions of voltage-gated Ca2+ channels to contractile responses in spontaneously hypertensive rat mesenteric arteries.Am J Hypertens. 1997 Nov;10(11):1231-9. doi: 10.1016/s0895-7061(97)00225-2. Am J Hypertens. 1997. PMID: 9397241
-
Rho-kinase, a potential therapeutic target for the treatment of hypertension.Drug News Perspect. 2004 Oct;17(8):523-7. doi: 10.1358/dnp.2004.17.8.863696. Drug News Perspect. 2004. PMID: 15605112 Review.
Cited by
-
Increased mitochondrial ROS generation mediates the loss of the anti-contractile effects of perivascular adipose tissue in high-fat diet obese mice.Br J Pharmacol. 2017 Oct;174(20):3527-3541. doi: 10.1111/bph.13687. Epub 2017 Jan 12. Br J Pharmacol. 2017. PMID: 27930804 Free PMC article.
-
Redox regulation of the actin cytoskeleton and its role in the vascular system.Free Radic Biol Med. 2017 Aug;109:84-107. doi: 10.1016/j.freeradbiomed.2017.03.004. Epub 2017 Mar 8. Free Radic Biol Med. 2017. PMID: 28285002 Free PMC article. Review.
-
Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.Pharmacol Ther. 2019 Jan;193:121-134. doi: 10.1016/j.pharmthera.2018.09.001. Epub 2018 Sep 4. Pharmacol Ther. 2019. PMID: 30189292 Free PMC article. Review.
-
The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.Am J Physiol Heart Circ Physiol. 2020 Apr 1;318(4):H867-H882. doi: 10.1152/ajpheart.00538.2019. Epub 2020 Mar 6. Am J Physiol Heart Circ Physiol. 2020. PMID: 32142358 Free PMC article.
-
Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.Fundam Clin Pharmacol. 2009 Apr;23(2):169-78. doi: 10.1111/j.1472-8206.2008.00658.x. Epub 2009 Mar 9. Fundam Clin Pharmacol. 2009. PMID: 19298234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical